ELV

Business Context and Reporting Period

This summary covers the Form 10-Q filed by WellPoint, Inc. (now Elevance Health) for the quarterly period ended March 31, 2006. WellPoint is the largest health benefits company in the U.S. by commercial membership, serving over 34 million members. The company operates through three segments: Health Care, Specialty, and Other. A significant event impacting this period was the acquisition of WellChoice, Inc., completed on December 28, 2005, which is included in the consolidated results for the first time.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Total revenues increased 26% year-over-year, driven primarily by the WellChoice acquisition, premium rate increases, and new Medicare Part D enrollment. On a comparable basis (excluding acquisition impact), revenue grew 10%.
• Profitability: Net income rose 20% to $731.8 million. Diluted EPS increased 11% to $1.09. The adoption of FAS 123R (share-based payment accounting) reduced reported net income by $25.7 million compared to prior accounting methods.
• Cost of Care: Benefit expense increased 26% to $10.2 billion. On a comparable basis, the expense ratio improved by 20 basis points to 81.3% due to disciplined pricing and moderating cost trends.
• Membership: Total medical membership reached 34.2 million, a 3% increase on a comparable basis. Notable growth occurred in National Accounts (+10%) and BlueCard (+12%), partially offset by a loss of 315,000 Large Group members in Georgia.
• Capital Allocation: The company repurchased approximately 24.7 million shares of common stock for $1.9 billion during the quarter. The Board authorized an additional $1.0 billion for repurchases, bringing the total program authorization to $3.0 billion.

Guidance, Outlook, and Risks

• Medical Cost Trends: Management estimates the 2006 medical cost of care trend to be less than 8%. Outpatient trends are moderating, while inpatient trends are driven by unit costs. Pharmacy cost trends remain unchanged but unit costs are declining due to generic usage.
• Medicare Part D: The company began marketing Medicare Part D plans in all 50 states on January 1, 2006, enrolling approximately 1.3 million members by March 31. Risks include underwriting assumptions, processing capabilities, and pharmaceutical cost volatility.
• Legal Contingencies: A settlement agreement regarding multi-district litigation (CMA, Shane, and Thomas Litigations) was approved by the court in early 2006. The company agreed to pay up to $198 million (including legal fees), though payments are pending the resolution of appeals. A pre-tax expense of $103 million was recorded in 2005.
• Accounting Changes: The company adopted FAS 123R effective January 1, 2006, requiring fair value accounting for stock-based compensation, which increased expenses and reduced net income.

Investor Verification Checklist

• WellChoice Integration: Verify the realization of synergies and the impact of the WellChoice acquisition on future margins and operating costs.
• Medical Claims Reserves: Review the sensitivity of the $5.16 billion medical claims payable liability to changes in completion and trend factors, as small adjustments can materially impact net income.
• Medicare Part D Performance: Monitor the profitability and enrollment stability of the new Medicare Part D business, given the complexity and regulatory risks associated with the program.
• Stock Repurchase Program: Track the remaining $1.1 billion authorization and the company's commitment to returning capital to shareholders amidst potential market volatility.
• Legal Settlement Appeals: Monitor the status of appeals regarding the $198 million litigation settlement to determine the timing and certainty of cash outflows.